Sugi Predict

Sugi Predict / Compounds / SCHEMBL227263

SCHEMBL227263

SCHEMBL227263

NC1=Cc2cc3ccccc3cc2C(=O)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.39
▸ NSD2 O96028 2/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ HKDC1 Q2TB90 1/20 0.38
▸ ALDH1A1 P00352 8/20 0.37
▸ PTPRC P08575 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ POLB P06746 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ APAF1 O14727 2/20 0.37
▸ TDP2 O95551 2/20 0.37
▸ PLA2G1B P04054 2/20 0.37
▸ PLCG1 P19174 2/20 0.37
▸ S100A4 P26447 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10591042 0.98 SLC2A1 (0.38) SLC2A1NSD2PTPN1HKDC1ALDH1A1
SCHEMBL10630648 0.98 SLC2A1 (0.38) SLC2A1NSD2PTPN1HKDC1ALDH1A1
SCHEMBL7945702 0.96 ALDH1A1 (0.39) SLC2A1NSD2PTPN1HKDC1ALDH1A1
SCHEMBL7898478 0.96 ALDH1A1 (0.39) SLC2A1NSD2PTPN1HKDC1ALDH1A1
SCHEMBL28122134 0.83 MAPK1 (0.45) ALDH1A1PTPRCMEN1KMT2ANPC1
SCHEMBL30805652 0.81 GSTP1 (0.38) ALDH1A1PTPRCMEN1POLBHTT
SCHEMBL9473429 0.77 CDC25A (0.42) ALDH1A1PTPRCMEN1POLBHTT
SCHEMBL3132658 0.77 MEN1 (0.34) ALDH1A1PTPRCMEN1POLBHTT
SCHEMBL2059539 0.77 ALDH1A1 (0.38) ALDH1A1PTPRCMEN1POLBHTT
SCHEMBL6233550 0.75 CDC25B (0.52) SLC2A1NSD2PTPN1HKDC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11635688-B2 Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2023-04-25 — — US claimed
US-9943465-B2 Methods of using a dental composition having an acidic component and a photobleachable dye 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-04-17 — — US claimed
EP-2846848-B1 OPHTHALMIC VISCOELASTIC DEVICE ZEISS CARL MEDITEC AG (DE) 2018-03-07 — — EP claimed
CN-106543027-A A kind of preparation method of amino anthraquinones structural compounds diazol, the modification dyeing of fibroin albumen 安徽工程大学 2017-03-29 — — CN claimed
US-20150119356-A1 Ophthalmic Viscoelastic Device CARL ZEISS MEDITEC AG (DE) 2015-04-30 — — US claimed
EP-2846848-A1 OPHTHALMIC VISCOELASTIC DEVICE Carl Zeiss Meditec AG (DE) 2015-03-18 — — EP claimed
US-20150024326-A1 PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES KAYAKU ADVANCED MATERIALS, INC. 2015-01-22 — — US claimed
WO-2013167632-A1 OPHTHALMIC VISCOELASTIC DEVICE CARL ZEISS MEDITEC AG (DE) 2013-11-14 — — WO claimed
WO-2013134104-A2 PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES MICROCHEM CORP. (US) 2013-09-12 — — WO claimed
WO-2013020917-A1 Ophthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide CARL ZEISS MEDITEC AG (DE) 2013-02-14 — — WO claimed
WO-2012173721-A1 EPOXY FORMULATIONS AND PROCESSES FOR FABRICATION OF OPAQUE STRUCTURES MICROCHEM CORP. (US) 2012-12-20 — — WO claimed
US-12189291-B2 Epoxy formulations and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2025-01-07 — — US disclosed
US-11635688-B2 Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2023-04-25 — — US disclosed
EP-2753662-B1 EPOXY FORMULATIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES MICROCHEM CORP (US) 2020-06-24 — — EP disclosed
CN-108219540-A Hybrid colored metallic pigments 唯亚威解决方案股份有限公司 2018-06-29 — — CN disclosed
EP-1068265-A1 THERMOPLASTIC RESIN COMPOSITION GENERAL ELECTRIC COMPANY (US) 2001-01-17 — — EP disclosed
US-5981600-A Hydroxyanthraquinone derivatives BAYKUT FIKRET (TR) 1999-11-09 — — US disclosed
WO-1999048968-A1 THERMOPLASTIC RESIN COMPOSITION GENERAL ELECTRIC COMPANY (US) 1999-09-30 — — WO disclosed
EP-0170290-B1 AMINO-ANTHRACENEDIONES-PLATINUM COMPLEXES USEFUL AS ANTI-CANCER COMPOUNDS BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1990-06-13 — — EP disclosed
US-4732893-A ANTITUMOR AGENTS BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1988-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119356-A1 Ophthalmic Viscoelastic Device UACA, ICAM1, VIM SLC2A1 3238/4885NSD2 3379/4885PTPN1 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.